An alarming threat to secondary prevention: Low compliance (Lifestyle) and poor adherence (Drugs);Un problema alarmante en prevención secundaria: Bajo cumplimiento (estilo de vida) y baja adherencia (farmacológica)

Revista Espanola de Cardiologia

Volumn 65, Issue SUPPL.2, 2012, Pages 10-16

  Fuster, Valentín ^a,b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Adherence; Ischemic cardiopathy; Lifestyle; Polypill; Secondary prevention

Indexed keywords

CARDIOVASCULAR AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; DISEASE COURSE; DRUG FORMULATION; EATING HABIT; EPIDEMIC; HEALTH CARE COST; HEALTH PRACTITIONER; HOSPITALIZATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; OBESITY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; SECONDARY PREVENTION; SMOKING CESSATION;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HEART DISEASES; HUMANS; LIFE STYLE; MEDICATION ADHERENCE; PATIENT COMPLIANCE; SECONDARY PREVENTION;

EID: 84865504901     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.07.005     Document Type: Article

References (20)

1. Institute of Medicine (IOM). Fuster V, Kelly BB, editores. Promoting cardiovascular health in the Developing World: A critical challenge to achieve global health. Washington: National Academies Press; 2010.
2. C.J. Murray, and A.D. Lopez Evidence-based health policy - lessons from the Global Burden of Disease Study Science 274 1996 740 743
3. L. Osterberg Adherence to medication N Engl J Med 353 2005 487
4. P. Muntner, D. Mann, R.P. Wildman, D. Shimbo, V. Fuster, and M. Woodward Projected impact of polypill use among US adults: Medication use, cardiovascular risk reduction, and side effects Am Heart J 161 2011 719 725
5. Yusuf S, Islam S, Chow CK, Rangarajan S, Dagenais G, Diaz R, et al. Prospective Urban Rural Epidemiology (PURE) Study Investigators. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middleincome, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet. 2011; 378:1231-43.
6. A.S. Gadkari, and C.A. McHorney Medication nonfulfillment rates and reasons: narrative systematic review Curr Med Res Opin 26 2010 683 705
7. Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. Disponible en: http://www.who.int/chronic- conditions/adherencereport/en/.
8. P.M. Ho, D.J. Magid, F.A. Masoudi, D.L. McClure, and J.S. Rumsfeld Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease BMC Cardiovasc Disord 6 2006 48
9. M.C. Roebuck, J.N. Liberman, M. Gemmill-Toyama, and T.A. Brennan Medication adherence leads to lower health care use and costs despite increased drug spending Health Aff (Millwood) 30 2011 91 99
10. D. Hevey, H.M. McGee, and J. Horgan Relationship of initial level of distress to changes in health-related quality of life during cardiac rehabilitation or usual care Psychosom Med 69 2007 793 797
11. K.L. Lapane, C.E. Dubé, K.L. Schneider, and B.J. Quilliam Misperceptions of patients vs providers regarding medication-related communication issues Am J Manag Care 13 2007 613 618
12. A.I. Goldberg, G. Cohen, and A.H. Rubin Physician assessments of patient compliance with medical treatment Soc Sci Med 47 1998 1873 1876
13. C.A. McHorney The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease Curr Med Res Opin 25 2009 215 238
14. M.R. DiMatteo Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research Med Care 42 2004 200 209
15. D.K. Ziegler, M.C. Mosier, M. Buenaver, and K. Okuyemi How much information about adverse effects of medication do patients want from physicians? Arch Intern Med 161 2001 706 713
16. B.J. Bailey, S.L. Carney, A.H. Gillies, L.M. McColm, A.J. Smith, and M. Taylor Hypertension treatment compliance: what do patients want to know about their medications? Prog Cardiovasc Nurs 12 1997 23 28
17. D.M. Tarn, D.A. Paterniti, R.L. Kravitz, J. Heritage, H. Liu, and S. Kim How much time does it take to prescribe a new medication? Patient Educ Couns 72 2008 311 319
18. D.M. Tarn, J. Heritage, D.A. Paterniti, R.D. Hays, R.L. Kravitz, and N.S. Wenger Physician communication when prescribing new medications Arch Intern Med 166 2006 1855 1862
19. S.L. Williams, K.B. Haskard, and M.R. DiMatteo The therapeutic effects of the physicianolder patient relationship: effective communication with vulnerable older patients Clin Interv Aging 2 2007 453 467
20. V. Fuster, B.B. Kelly, and R. Vedanthan Promoting global cardiovascular health: moving forward Circulation 123 2011 1671 1678